TuHURA Biosciences Announces Participation in Upcoming Investor Conferences

TuHURA Biosciences Announces Participation in Upcoming Investor Conferences [Accessibility Statement] Skip NavigationTAMPA, Fla., Feb. 24, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that Dr. James Bianco, President and Chief Executive Officer, will participate in the following upcoming investor conferences:Citizens Life Science Conferen ...